ArticleJournal of pharmaceutical health care and sciences2023
Risk factors for thromboembolism during first-line treatment of patients with unresectable advanced or recurrent colorectal cancer: a retrospective short study.
Ryo Takada et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.